Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

A. Morabito, M.C. Piccirillo, P. Maione, A. Luciani, L. Cavanna, L. Bonanno, V. Filipazzi, S. Leo, S. Cinieri, F. Morgillo, M.A. Burgio, D. Ferrara, F. Rosetti, R. Bianco, F. Artioli, D. Cortinovis, V. Gebbia, V. Fregoni, M. Mencoboni, C. SandomenicoA. Rossi, A. Montanino, A. Manzo, G. Rocco, L. Arenare, G. Daniele, S. Signoriello, C. Gallo, F. Perrone, C. Gridelli

Research output: Contribution to journalArticlepeer-review

Cite this